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Abstract: Purpose. We aimed to investigate comparability of LV volumes, function, and mass acquired with 
three steady-state free precession (SSFP) pulse sequences, simulating typical vendor and protocol specific 
differences in data acquisition.  
Methods. Twenty-one healthy subjects (11 male and 10 female; age range 23-49) underwent cardiac 
magnetic resonance (CMR) imaging at 1.5 Tesla (T). A complete stack of short-axis views covering the 
entire left ventricle (LV) were acquired for each of the three SSFP sequences, differing in the interslice gap 
and slice thickness (7mm with no gap (7/0mm); 7mm with a 3mm gap (7/3mm) and 6mm with a 4mm gap 
(6/4mm)) with slight variations in acquisition parameters.  For each sequence, the LV volumes, function, and 
mass were determined. Intra- and inter-observer variability and inter-study reproducibility were assessed for 
all protocols. 
Results. All LV volumes, function and mass parameters were similar for the three SSFP sequences (p>0.05 
for all).  The LV ejection fraction for the 7/3 mm sequence was 67.2 ± 6.0, 67.4 ± 5.3 for the 7/0mm 
sequence, and the 6/4 mm sequence was 69.2 ± 5.7.  The LV mass ranged from 119.8 ± 32.4 for the 7/3 
mm sequence to 122.2 ± 34.0 for the 7/0 mm sequence.  Variabilities were low with no difference in 
variability between the sequences.  
Conclusion. The three SSFP pulse sequence techniques resulted in similar LV volume, function, and mass 
measurements with no difference in observer and interstudy variabilities. This may allow application and 
transfer of LV volume studies and databases based on different imaging parameters, at different CMR sites, 
with a given post-processing method. Future multi-centre studies may now be in a position to consider multi-
vendor study designs for LV volume studies.
Comments from Reviewer #1:
We would like to thank the reviewer for his/her thoughtful comments. In the revised 
version, we have incorporated all suggestions. We feel that this has considerably 
strengthened the manuscript.
This paper describes the effect of relatively small variations in MRI SSFP pulse sequence 
upon calculated cardiac functional parameters. The authors show that results from 
different groups may be compared if the applies pulse sequence does not vary too much. 
This is an interesting result.
Questions:
Relatively large differences in observed LV-mass appear (intraobserver) from the Bland-
Altman plot. Please comment on this in the discussion section. A major difference in the 
pulse sequence 6/4 as compared to the others is the pixel size: in plane resolution 
1.5x1.5mm versus ~1.9x1.5mm; this should be noted in the discussion section, it might 
have consequences for the quantitative results.
Response:
The intra-observer variability for LV mass was found to be in the range of 4.2% (6/4 mm 
technique) to 5.8% (7/0 mm technique). These are acceptable values for intra-observer 
variabilities and agree with many published studies applying cardiac magnetic resonance 
imaging for determination of LV mass. 
We have added the following sentence to the second paragraph in the discussion: “The 
lower spatial resolution of the 6/4 mm technique (1.9 x 1.5 mm) compared to the other 
two techniques (1.5 x 1.5 mm) may also contribute to the observed trend for differences 
in LV end-systolic volume and ejection fraction.”
Comments from Reviewer #2:
We would like to thank the reviewer for his/her thoughtful comments. In the revised 
version, we have incorporated all suggestions. We feel that this has considerably 
strengthened the manuscript.
 The authors present the results of a study comparing LV volumes, function, and mass 
acquired with three steady-state free precession (SSFP) pulse sequences.  Their main 
findings include
- All LV volumes, function and mass parameters were similar for the three SSFP 
sequences (p>0.05 for all)
- Variabilities were low with no difference in variability between the sequences. The 
authors conclude that their findings may allow application and transfer of LV volume 
studies and databases based on different imaging parameters at different CMR sites, and 
that future multi-centre studies may now be in a position to consider multivendor study 
designs for LV volume studies.
General Comments
1. What was the reason to believe that the results from the different protocols would vary 
significantly?  The hypothesis (page 2) seems awkward. 
* Response to reviewer's comments
Click here to download Response to reviewer's comments: rebuttal_Letter_v2_1Nov2006.doc
Response: The main aim of our study was to investigate whether there would be 
clinically relevant differences among the LV volume results based on three different MR 
sequences. Work in this area with sequences that differ more than ours (i.e. ref [3] Moon, 
and ref [6] Kunz et al.) do find differences, and so it is not obvious that we would find no 
difference between these more similar approaches.  As we were not expecting significant 
differences, we have now altered our hypothesis in the introduction as follows:
“We hypothesized there would not be a significant difference among the three SSFP 
pulse sequence techniques.” 
2. The cardiology community has lived with fairly poor interobserver and intraindividual 
variability of echo measures but this has never hindered anybody to use 
echocardiography to measure LV function in multicenter trials.  In addition, in clinical 
trials the effect of measurement variability on sample size is small compared to the effect 
of expected difference between treatment groups. 
Response: We entirely agree with the reviewer that echocardiography with poorer 
observer variability has been widely used in multicentre trials. This was mainly due to the 
low cost of echo studies and the widespread availability of echo machines. However, 
recent studies suggest that due to the markedly reduced variability in determination of LV 
mass, LV volumes etc using cardiac MRI sample size for multicentre studies can be 
dramatically reduced by up to 97% depending on the parameter of interest (Bellenger NG 
et al, J Cardiovasc Magn Reson; 2000;2(4):271-8). This may lead to an actual reduction 
in the cost of multicentre trials. So for a given expected difference between treatment 
groups, the improved variability of cardiac MRI allows a substantial reduction of sample 
size.
3. The study group consisted of young patients, who were lean, and had a low heart rate.  
Left ventricular morphology was normal in all, and the range of ejection fraction was 
very narrow.  This limits the generalizability of the authors' findings to patients with 
(severe) cardiovascular disease and abnormal heart rhythms, LV geometry and ejection 
fractions.
Response: This is a very valuable comment. We have added a sentence of caution to our 
discussion to extrapolate these findings to diseased hearts. We would hope that given the 
coverage of the entire heart, geometric assumptions are minimal and would not lead to 
relevant differences among the three sequences.
Our conclusion now reads as follows:
“We have shown the LV volume, function, and mass parameters acquired at 1.5T using 
three SSFP pulse sequence techniques in healthy controls are comparable and 
interchangeable.  This finding is particularly important for patients receiving care in 
different geographical locations and may allow multi-centre trials to include multiple 
vendor CMR centers, optimizing patient recruitment. However, future studies may need 
to confirm our findings in patients with dilated or hypertrophied hearts.”
Specific Comments
1. Page 4, para 3: "… even small differences in cardiac parameters can influence 
patient treatment and prognosis."  From a clinician's perspective this is not true.  If 
you want to keep this sentence, should provide a reference that supports the "small 
differences" notion. 
Response: We agree that the prognosis of a patient does not change significantly with 
minor changes in ejection fraction. We have therefore changed this sentence in the 
introduction accordingly. However, we feel that clinical management decisions are 
based on rather arbitrary cut-off values and therefore minor changes can alter patient 
management, e.g. in the indication for implantable cardioverter defibrillators or 
cardiac re-synchronisation therapy. We have therefore added an example to the 
introduction which now reads as follows:
“From a clinical perspective, it is critically important that results obtained from 
different CMR machines and from various manufacturers are interchangeable as even 
small differences in cardiac parameters can influence patient treatment, e.g 
Implantable cardioverter defibrillator indications are partly based on cut-off values for 
ejection fraction of less than 30 or 35%.”
2. Please explain your methods in more detail.  It is ultimately not clear whether each 
examiner imaged only a few patients and analyzed their images (I suspect this is the 
case based on your description of analyzing interobserver variability), or if all 
examiners were involved with the analysis of all studies from all patients.  What was 
the rationale for your study design? 
Response: We apologize that this has not been clear enough. Essentially, three 
examiners JMF, LEH and SEP performed the MR investigations. The whole dataset, 
including the repeat scans for interstudy reproducibility, was analyzed by MEH who 
also re-analyzed the images for intra-observer variability. JMF analyzed the data for 
inter-observer variability.
We changed our methods section and hope that this now clarifies this further:
“The inter-study reproducibility was assessed (MEH) by re-imaging seven subjects 
one to two days after the first scan.  Inter-observer variability was assessed by a 
second observer, analyzing seven of the data sets (JMF). For the intra-observer 
variability, one observer (MEH) analyzed the first seven data sets and waited six 
weeks to re-analyze the same seven data sets.”  
3. Page 6, para 2:  How did you decide on the specific parameter setting for the 
various imaging sequence permutations?  Were they realistically modeled after the 
sequence parameters from other manufacturers? 
Response:
The specific sequence parameter settings were duplicated from those used in previous 
published works.  Specifically, refs Alfakih et al, Moon et al and Hudsmith et al.  
The text now described the parameters used in the context of this previous work.
“After localization and piloting, a short-axis stack was acquired parallel to the 
atrioventricular groove to cover the entire left ventricle in the standard way [12,13]
for the 7/3mm (TE/TR 1.5/3.0 ms, flip angle 60o, temporal resolution 45ms, 
slices/breathold 1, matrix size 256 x 202, field of view 380 x 309 mm) identical to 
those parameters described by Hudsmith et al[12] and consistent with the parameters 
used by Moon et al [3], 7/0mm (TE/TR 1.5/3.0 ms, flip angle 60o, temporal resolution 
45ms, slices/breath-hold 1, matrix size 256 x 202, field of view 380 x 309 mm) as the 
above sequence but without the 3mm gaps, and 6/4mm sequences (TE/TR 1.7/3.4 ms, 
flip angle 55o, temporal resolution 42ms, slices/breath-hold 2, matrix size 192 x 192, 
field of view 360 x 292 mm) duplicating that of the parameters described by Alfakih 
et al[1].  ”
4. Page 7, para 2:  How was the analysis blinded?  Was all information pertaining to 
patients and imaging parameters removed from the images? 
Response:
This is correct. The usual information regarding sequence parameters and patient 
details were removed by a person not involved in the analysis. 
5. Page 8, para 1:  "The inter-study reproducibility was assessed by re-imaging seven 
subjects."  At what interval?  If during the same imaging session, were patients taken 
off the table,  ECG leads taken off and re-applied?
Response:
To study true inter-study reproducibility we re-imaged the subjects within 1-2 days of 
the first study. New positioning on the table, new ECG lead positioning, re-piloting 
the heart for acquisition of the short axis stack of cine images were therefore 
contributing to the inter-study variability. This is therefore true interstudy 
reproducibility rather than just re-imaging in the same position a few minutes after the 
first scan. We have therefore added this missing information to the revised 
manuscript: “The inter-study reproducibility was assessed by re-imaging seven 
subjects one to two days after the first scan.”
Finally, please, add one or more references on the same or similar subject from 
earlier issues of the Int J Cardiovascular Imaging
Response:
We have added two more references from earlier issues of the Int J Cardiovascular 
Imaging as requested. Darasz et al and Mao et al. We did not consider any of the other 
publications appropriate for inclusion in the reference list.
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ABSTRACT
Purpose. We aimed to investigate comparability of LV volumes, function, and mass 
acquired with three steady-state free precession (SSFP) pulse sequences, simulating 
typical vendor and protocol specific differences in data acquisition.  
Methods. Twenty-one healthy subjects (11 male and 10 female; age range 23-49) 
underwent cardiac magnetic resonance (CMR) imaging at 1.5 Tesla (T). A complete 
stack of short-axis views covering the entire left ventricle (LV) were acquired for each of 
the three SSFP sequences, differing in the interslice gap and slice thickness (7mm with 
no gap (7/0mm); 7mm with a 3mm gap (7/3mm) and 6mm with a 4mm gap (6/4mm)) 
with slight variations in acquisition parameters.  For each sequence, the LV volumes, 
function, and mass were determined. Intra- and inter-observer variability and inter-study 
reproducibility were assessed for all protocols. 
Results. All LV volumes, function and mass parameters were similar for the three SSFP 
sequences (p>0.05 for all).  The LV ejection fraction for the 7/3 mm sequence was 67.2 ± 
6.0, 67.4 ± 5.3 for the 7/0mm sequence, and the 6/4 mm sequence was 69.2 ± 5.7.  The 
LV mass ranged from 119.8 ± 32.4 for the 7/3 mm sequence to 122.2 ± 34.0 for the 7/0 
mm sequence.  Variabilities were low with no difference in variability between the 
sequences.  
Conclusion. The three SSFP pulse sequence techniques resulted in similar LV volume, 
function, and mass measurements with no difference in observer and interstudy 
variabilities. This may allow application and transfer of LV volume studies and databases 
3based on different imaging parameters, at different CMR sites, with a given post-
processing method. Future multi-centre studies may now be in a position to consider 
multi-vendor study designs for LV volume studies.
Abbreviations: ANOVA-analysis of variance; CMR-Cardiovascular magnetic resonance; 
CoV-Coefficient of variability; FISP- Fast imaging with steady state precession; FLASH-
Fast low angle shot; Magnetic resonance imaging (MRI); T-Tesla; TE-Echo time; TR-
Repetition time; LV-Left ventricle; SD-Standard deviation; SSFP-Steady-state free 
precession.
4INTRODUCTION 
Cardiovascular magnetic resonance (CMR) imaging is accurate and reproducible in 
measuring left ventricular (LV) volumes[1-3].  Evaluation of cardiac function parameters 
is necessary to diagnose heart disease and monitor ventricular function[4].  To diagnose, 
assess prognosis, and evaluate a patient’s response to therapy, cardiac function 
parameters must be both accurate and reproducible [5-7].  
The steady-state free precession (SSFP) pulse sequence at 1.5 Tesla (T) has been 
accepted as the preferred acquisition technique for cardiac functional assessment because 
it provides high-quality images with improved border definition compared to gradient 
echo sequences, such as the fast low angle shot sequence (FLASH) [3].  SSFP is the 
sequence of choice for analysis of ventricular function because of the excellent 
endocardial contour contrast, resulting from the contrast between the ventricular blood 
and myocardium and between the myocardium and epicardial fat [8].  Further, this pulse 
sequence has been validated in animal models [9,10].
Different manufacturers of CMR machines alter subtle aspects of the SSFP acquisition 
parameters, such as resolution, flip angle, slice thickness, and interslice gap.  From a 
clinical perspective, it is critically important that results obtained from different CMR 
machines and from various manufacturers are interchangeable as even small differences 
in cardiac parameters can influence patient treatment,e.g Implantable cardioverter 
defibrillator indications are partly based on cut-off values for ejection fraction of less 
than 30 or 35%. .  Various groups have determined cardiac parameters using SSFP for 
5normal populations [1,11,12].  Although all these sequences are described as SSFP, it is 
unclear whether the cardiac volume, function, and mass measurements are comparable 
with different acquisition parameters.  Moon and colleagues [3] have previously 
demonstrated that different sequences, FLASH and SSFP, result in significantly different 
left ventricular volumes and masses. Different parameter selection and slice thickness 
within the SSFP sequence may also influence cardiac parameters.  To date, no study has 
compared variations within the SSFP pulse sequence technique.  
The accuracy and reproducibility of breathhold CMR in analyzing cardiac volumes, 
function, and mass in heart failure compared to echocardiography allows for a reduction 
in the number of patients needed to prove a hypothesis in clinical trials [5].  We propose 
that if SSFP pulse sequence techniques are interchangeable from site-to-site, then multi-
center trials will benefit because CMR will allow for combining patients from different 
sites.   
The purpose of this study was to compare three SSFP pulse sequence techniques with 
slight variations in slice thickness and interslice gap, flip angle, repetition time (TR), 
echo time (TE), matrix size, and field of view, to determine if the techniques are 
comparable and therefore interchangeable.  We hypothesized there would not be a 
significant difference among the three SSFP pulse sequence techniques.
6METHODS
Study Population
Twenty-one healthy subjects with a mean age of 30 ± 7 years (11 males, 10 females) 
were investigated. All subjects were non-smokers with no family history of coronary 
artery disease and a normal resting electrocardiogram. The mean blood pressure was (123 
± 15)/ (77 ± 10 mmHg), heart rate was 63 ± 11 bpm, the mean weight was 72 ± 13 kg 
with a mean body mass index of 24 ± 3 kg/m2 and mean body surface area was 1.86 ± 
0.19 m2. Subjects with typical contraindications to magnetic resonance imaging (MRI), 
such as claustrophobia or pacemakers, were excluded.  The study was carried out 
according to the principles of the Declaration of Helsinki and was approved by our 
institutional ethics committee. Each volunteer gave informed written consent.
Magnetic Resonance Imaging Protocol
All subjects were examined on a 1.5T Siemens Sonata imager (Siemens Medical 
Solutions, Erlangen, Germany) with Syngo software Version 21B, equipped with high 
performance gradients (40mT/m peak, 200T/m/s slew-rate), prospective 
electrocardiographic gating and the subject in the supine position. A standard six-channel 
anterior cardiac array and two-elements of the integrated spine array coil were used. 
Three experienced operators performed the scans (LEH, SEP, JMF). After localization 
and piloting, a short-axis stack was acquired parallel to the atrioventricular groove to 
cover the entire left ventricle in the standard way [12,13] for the 7/3mm (TE/TR 1.5/3.0 
ms, flip angle 60o, temporal resolution 45ms, slices/breathold 1, matrix size 256 x 202, 
7field of view 380 x 309 mm) identical to those parameters described by Hudsmith et 
al[12] and consistent with the parameters used by Moon et al [3], 7/0mm (TE/TR 1.5/3.0 
ms, flip angle 60o, temporal resolution 45ms, slices/breath-hold 1, matrix size 256 x 202, 
field of view 380 x 309 mm) as the above sequence but without the 3mm gaps, and 
6/4mm sequences (TE/TR 1.7/3.4 ms, flip angle 55o, temporal resolution 42ms, 
slices/breath-hold 2, matrix size 192 x 192, field of view 360 x 292 mm) duplicating that 
of the parameters described by Alfakih et al[1].  All images were acquired during breath-
hold in end-expiration. The total examination time was approximately 40 minutes for 
each subject.
Image Analysis 
Blinded analysis was performed using Argus software (Version 2002B, Siemens Medical 
Solutions, Erlangen, Germany). The end-systolic and end-diastolic frames were 
independently chosen by each observer.  Using the standard format [12,13] on each end-
diastolic frame, endocardial and epicardial borders were manually traced, and an 
endocardial border was manually traced on each end-systolic frame . The end-diastolic 
frame was defined as the image with the largest ventricular volume in each series, and the 
image with the smallest ventricular volume was chosen as the end-systolic frame.  The 
interventricular septum was included as a part of the left ventricle.  From these data, the 
ejection fraction, LV end-diastolic volume, LV end-systolic volume, stroke volume, and 
LV mass were calculated.  Myocardial mass was calculated by multiplication of the tissue 
volume by 1.05 g/cm3  (specific density of myocardium).
8Reproducibility and Variability
The inter-study reproducibility was assessed (MEH) by re-imaging seven subjects one to 
two days after the first scan.  Inter-observer variability was assessed by a second 
observer, analyzing seven of the data sets (JMF). For the intra-observer variability, one 
observer (MEH) analyzed the first seven data sets and waited six weeks to re-analyze the 
same seven data sets.  
Statistical Analysis 
All data are presented as mean +/- standard deviation (SD) unless stated otherwise. Inter-
study reproducibility, inter- and intra-observer variability were assessed using the method 
of Bland and Altman [14]. The coefficient of variability (CoV) was calculated as the SD 
of the differences between the two sets of measurements divided by the mean value of the 
parameter under consideration. Repeated measures of analysis of variance (ANOVA) 
were used to test for differences for continuous parameters among the three sequences 
used. Throughout the analyses, a two-sided p-value of <0.05 was considered statistically 
significant. All computations were performed with SPSS 11.5 (SPSS Inc., Chicago, US). 
Sample size calculations were performed before the initiation of the study based on the 
following assumptions: repeated measures ANOVA, SD for LV mass in healthy 
population [1], power 90%, alpha 0.05 and a difference of 10% of LV mass as the change 
to be detected. 
9RESULTS 
CMR imaging was well tolerated by all subjects. All datasets were of good image quality 
and included in the study.  Images acquired of a healthy female subject using the three 
SSFP pulse sequence techniques are shown in Figure 1.    
The LV volumes, function and mass for each sequence are displayed in Table 1. There 
was no significant difference in all LV parameters using the three acquisition techniques 
(p>0.05), with similar normal ranges for healthy volunteers.  There was a trend for 
sequence 6/4mm to have an increased LV ejection fraction (p=0.07) and a reduced end-
systolic volume (p=0.05).  
There was no systematic difference in variabilities for the three sequences (Table 2).  The 
LV ejection fraction and LV mass for the intraobserver variability are displayed in Figure 
2.  The intraobserver variability was lowest using the 6/4mm technique for the LV 
ejection fraction, LV end-diastolic volume, and LV mass.  For the LV ejection fraction, 
the interobserver variability was lowest for the 7/3 mm technique, and highest for the 
6/4mm technique.  
10
DISCUSSION 
The purpose of this study was to quantify LV volumes, function and mass using three 
SSFP pulse sequence techniques to assess if the techniques are comparable and therefore 
interchangeable. We have shown that the three pulse sequences result in no significant 
differences in left ventricular volumes, function, and mass. Our results for the 6/4mm 
technique were comparable to the normal range of cardiac parameters published by 
Alfakih et al, using a Philips 1.5 T SSFP sequence using a 6 mm slice and 4 mm gap[1].  
The normal range published by Hudsmith et al using a Siemens 1.5 T SSFP sequence
with a 7 mm slice and 3 mm gap showed cardiac parameters similar to our 7/3mm 
technique[12].  Kunz et al [8] examined left ventricular parameters using a contiguous 
8/0mm technique using a Siemens 1.5T SSFP sequence, showing results similar to our 
7/0mm contiguous technique.  
There was no significant difference in LV mass for all three sequences.  The 6/4mm 
technique showed a trend towards a decreased end-systolic volume.  This is possibly due 
to the larger interslice gap, leading to more geometric assumptions. The 6/4mm technique 
had a trend towards an increased ejection fraction.  The 6/4mm technique had a higher 
temporal resolution (i.e. lower TR) than the other two techniques, and therefore the 
captured end-systolic frame may be closer to the true end-systole, resulting in higher 
ejection fractions when compared to the two other sequences with lower temporal 
resolution. The lower spatial resolution of the 6/4 mm technique (1.9 x 1.5 mm) 
compared to the other two techniques (1.5 x 1.5 mm) may also contribute to the observed 
trend for differences in LV end-systolic volume and ejection fraction. 
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One would assume that although the 7/0mm technique has the longest acquisition time, it 
would be clinically superior to the other techniques because images are acquired 
contiguously, covering the entire ventricle, thus eliminating any gaps and not relying on 
geometric assumptions.  However, this study has shown that patient examination time can 
be minimized by using technique 7/3mm and 6/4mm, and result in similar and 
interchangeable cardiac parameter measurement.  The application of these two techniques 
are therefore valuable in a time-pressured clinical environment.   
The variability measurements of this study are comparable with those reported in the 
literature [1,3,11-13]. Overall, our results show low variability for all LV volumes, 
function, and mass results.  These variability data show that the tested techniques are 
reproducible and can be used in clinical practice. 
The LV ejection fraction is a frequently used cardiac functional  prognostic factor for 
patients, particularly in monitoring responses to therapeutic intervention [15] .  We have 
shown these three techniques provide the same information regardless of the 
manufacturer.  This is important for patients receiving care in different geographical 
locations or within a multi-centre trial.  We have provided evidence that may allow 
application and transfer of LV volume databases based on slightly different SSFP 
parameters, slice thickness and inter-slice gaps at different MRI sites, given a similar 
approach to post-processing. Future multi-centre studies may now be in a position to 
consider multi-vendor study designs for LV volume studies, aiding recruitment.
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It is probable that variability in cardiac parameters result from variations in operators.  
Intra- and inter-operator variability studies of manual planning of CMR imaging resulted 
in insignificant statistical differences on LV parameters [16].  Because the variations due 
to different operators are insignificant, it was important to analyze if the errors were the 
result of the difference in the manufacturer, as completed in our study.  
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CONCLUSION 
We have shown the LV volume, function, and mass parameters acquired at 1.5T using 
three SSFP pulse sequence techniques in healthy controls are comparable and 
interchangeable.  This finding is particularly important for patients receiving care in 
different geographical locations and may allow multi-centre trials to include multiple 
vendor CMR centers, optimizing patient recruitment. However, future studies may need 
to confirm our findings in patients with dilated or hypertrophied hearts.
14
FIGURE LEGEND
Figure 1: Mid-ventricular short axis slices acquired during end-diastole in a healthy 
female subject using three steady-state free precession pulse sequence techniques, with 
endocardial and epicardial contours drawn on the left ventricle. A: 7 mm slice thickness 
with a 3 mm gap, one slice per breath-hold. B: contiguous images acquired with no gap at 
7mm, one slice per breath-hold. C: 6 mm slice thickness with a 4 mm gap, two slices per 
breath-hold. 
Figure 2: Intraobserver variability for LV mass and LV ejection fraction using the steady 
state free precession sequence without interslice gap for 7 healthy subjects (Bland-
Altman plot [14]). 
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Table 1: LV measurements in 21 healthy subjects
7/3mm 7/0mm 6/4mm P value
Ejection fraction (%)
67.2 ± 6.0 
(64.5-70.0)
67.4 ± 5.3
(65.0-69.8)
69.2 ± 5.7
(66.6-71.8)
0.07
Mass (g)
119.8 ± 32.4
(105.1-134.5)
122.2 ± 34.0
(106.6-137.7)
119.8 ± 33.6
(104.5-135.1)
0.35
End-diastolic volume (ml)
155.8 ± 34.0
(140.3-171.2)
159.7 ± 36.3
(143.2-176.2)
157.8 ± 34.7
(142.1-173.6)
0.10
End-systolic volume (ml)
50.6 ± 12.9
(44.8-56.5)
52.3 ± 16.0
(45.0-59.6)
48.2 ± 12.3
(42.6-53.8)
0.05
Stroke volume (ml)
105.1 ± 27.0
(92.8-117.4)
107.4 ± 24.4
(96.3-118.5)
109.7 ± 27.5
(97.2-122.2)
0.14
Values are expressed as Mean ± SD (95% confidence interval); ANOVA was used to test 
for differences for continuous parameters among the three sequences; p<0.05 is 
statistically significant.  
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Table 2: Variability of left ventricular measurements 
Intraobserver Interobserver Interstudy
Bias
(95% limits of 
agreement)
CoV
Bias
(95% limits of 
agreement)
CoV
Bias
(95% limits of 
agreement)
CoV
Ejection 
Fraction (%)
7/3mm
1.36 ± 3.43
(-5.36-8.08)
5.3
-2.75 ±  1.78
(-6.24-0.75)
2.8
2.06 ± 4.97
(-7.67-11.80)
7.8
Ejection 
Fraction (%)
7/0mm
3.14 ± 5.78
(-8.19-14.47)
9.1
-1.54 ±  2.91
(-7.24-4.15)
4.6
2.36 ± 5.40
(-8.22-12.95)
8.4
Ejection 
Fraction (%)
6/4mm
0.43 ± 2.49
(-4.45-5.31)
3.7
-1.19 ±  4.67
(-10.35-7.97)
7.2
2.47 ± 4.48
(-6.32-11.26)
6.8
Mass (g)
7/3mm
4.26 ± 6.67
(-8.80-17.33)
5.6
5.63 ±  10.28
(-14.51-25.77)
9.0
4.71 ± 12.21  
(-19.23-28.65)
10.3
Mass (g)
7/0mm
1.67 ± 6.94
(-11.93-15.27)
5.8
9.07 ±  7.53
(-5.69-23.82)
6.5
-0.74 ± 10.72
(-21.75-20.26)
8.9
Mass (g)
6/4mm
4.18 ± 4.95
(-5.51-13.88)
4.2
4.93 ± 9.54
(-13.77-23.63)
8.3
2.21 ± 14.85
(-26.90-31.32)
12.5
End-diastolic 
volume (ml)
7/3mm
-6.61 ± 9.14
(-24.52 – 11.30)
6.9
10.17 ±  6.57
(-2.70-23.04)
4.6
-0.73 ± 12.62
(-25.48 – 24.01)
8.5
End-diastolic 
volume (ml)
7/0mm
-6.45 ± 8.15
(-22.42 – 9.53)
5.3
13.17 ±  8.13
(-2.77-29.10)
5.6
-1.97 ± 14.22
(-29.83 – 25.89)
9.5
End-diastolic 
volume (ml)
6/4mm
-5.73 ± 7.56
(-20.54 - 9.09)
5.0
13.09 ±  15.05
(-16.41-42.59)
10.6
0.10 ± 18.98
(-37.10 – 37.29)
12.8
Values are expressed as Mean ± SD (95% confidence interval); CoV= coefficient of 
variability; Mean and confidence interval determined according to the Bland and Altman 
method [14].
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ABSTRACT
Purpose. We aimed to investigate comparability of LV volumes, function, and mass 
acquired with three steady-state free precession (SSFP) pulse sequences, simulating 
typical vendor and protocol specific differences in data acquisition.  
Methods. Twenty-one healthy subjects (11 male and 10 female; age range 23-49) 
underwent cardiac magnetic resonance (CMR) imaging at 1.5 Tesla (T). A complete 
stack of short-axis views covering the entire left ventricle (LV) were acquired for each of 
the three SSFP sequences, differing in the interslice gap and slice thickness (7mm with 
no gap (7/0mm); 7mm with a 3mm gap (7/3mm) and 6mm with a 4mm gap (6/4mm)) 
with slight variations in acquisition parameters.  For each sequence, the LV volumes, 
function, and mass were determined. Intra- and inter-observer variability and inter-study 
reproducibility were assessed for all protocols. 
Results. All LV volumes, function and mass parameters were similar for the three SSFP 
sequences (p>0.05 for all).  The LV ejection fraction for the 7/3 mm sequence was 67.2 ± 
6.0, 67.4 ± 5.3 for the 7/0mm sequence, and the 6/4 mm sequence was 69.2 ± 5.7.  The 
LV mass ranged from 119.8 ± 32.4 for the 7/3 mm sequence to 122.2 ± 34.0 for the 7/0 
mm sequence.  Variabilities were low with no difference in variability between the 
sequences.  
Conclusion. The three SSFP pulse sequence techniques resulted in similar LV volume, 
function, and mass measurements with no difference in observer and interstudy 
variabilities. This may allow application and transfer of LV volume studies and databases 
3based on different imaging parameters, at different CMR sites, with a given post-
processing method. Future multi-centre studies may now be in a position to consider 
multi-vendor study designs for LV volume studies.
Abbreviations: ANOVA-analysis of variance; CMR-Cardiovascular magnetic resonance; 
CoV-Coefficient of variability; FISP- Fast imaging with steady state precession; FLASH-
Fast low angle shot; Magnetic resonance imaging (MRI); T-Tesla; TE-Echo time; TR-
Repetition time; LV-Left ventricle; SD-Standard deviation; SSFP-Steady-state free 
precession.
4INTRODUCTION 
Cardiovascular magnetic resonance (CMR) imaging is accurate and reproducible in 
measuring left ventricular (LV) volumes[1-3].  Evaluation of cardiac function parameters 
is necessary to diagnose heart disease and monitor ventricular function[4].  To diagnose, 
assess prognosis, and evaluate a patient’s response to therapy, cardiac function 
parameters must be both accurate and reproducible [5-7].  
The steady-state free precession (SSFP) pulse sequence at 1.5 Tesla (T) has been 
accepted as the preferred acquisition technique for cardiac functional assessment because 
it provides high-quality images with improved border definition compared to gradient 
echo sequences, such as the fast low angle shot sequence (FLASH) [3].  SSFP is the 
sequence of choice for analysis of ventricular function because of the excellent 
endocardial contour contrast, resulting from the contrast between the ventricular blood 
and myocardium and between the myocardium and epicardial fat [8].  Further, this pulse 
sequence has been validated in animal models [9,10].
Different manufacturers of CMR machines alter subtle aspects of the SSFP acquisition 
parameters, such as resolution, flip angle, slice thickness, and interslice gap.  From a 
clinical perspective, it is critically important that results obtained from different CMR 
machines and from various manufacturers are interchangeable as even small differences 
in cardiac parameters can influence patient treatment,e.g Implantable cardioverter 
defibrillator indications are partly based on cut-off values for ejection fraction of less 
than 30 or 35%. .  Various groups have determined cardiac parameters using SSFP for 
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5normal populations [1,11,12].  Although all these sequences are described as SSFP, it is 
unclear whether the cardiac volume, function, and mass measurements are comparable 
with different acquisition parameters.  Moon and colleagues [3] have previously 
demonstrated that different sequences, FLASH and SSFP, result in significantly different 
left ventricular volumes and masses. Different parameter selection and slice thickness 
within the SSFP sequence may also influence cardiac parameters.  To date, no study has 
compared variations within the SSFP pulse sequence technique.  
The accuracy and reproducibility of breathhold CMR in analyzing cardiac volumes, 
function, and mass in heart failure compared to echocardiography allows for a reduction 
in the number of patients needed to prove a hypothesis in clinical trials [5].  We propose 
that if SSFP pulse sequence techniques are interchangeable from site-to-site, then multi-
center trials will benefit because CMR will allow for combining patients from different 
sites.   
The purpose of this study was to compare three SSFP pulse sequence techniques with 
slight variations in slice thickness and interslice gap, flip angle, repetition time (TR), 
echo time (TE), matrix size, and field of view, to determine if the techniques are 
comparable and therefore interchangeable.  We hypothesized there would not be a 
significant difference among the three SSFP pulse sequence techniques.
6METHODS
Study Population
Twenty-one healthy subjects with a mean age of 30 ± 7 years (11 males, 10 females) 
were investigated. All subjects were non-smokers with no family history of coronary 
artery disease and a normal resting electrocardiogram. The mean blood pressure was (123 
± 15)/ (77 ± 10 mmHg), heart rate was 63 ± 11 bpm, the mean weight was 72 ± 13 kg 
with a mean body mass index of 24 ± 3 kg/m2 and mean body surface area was 1.86 ± 
0.19 m2. Subjects with typical contraindications to magnetic resonance imaging (MRI), 
such as claustrophobia or pacemakers, were excluded.  The study was carried out 
according to the principles of the Declaration of Helsinki and was approved by our 
institutional ethics committee. Each volunteer gave informed written consent.
Magnetic Resonance Imaging Protocol
All subjects were examined on a 1.5T Siemens Sonata imager (Siemens Medical 
Solutions, Erlangen, Germany) with Syngo software Version 21B, equipped with high 
performance gradients (40mT/m peak, 200T/m/s slew-rate), prospective 
electrocardiographic gating and the subject in the supine position. A standard six-channel 
anterior cardiac array and two-elements of the integrated spine array coil were used. 
Three experienced operators performed the scans (LEH, SEP, JMF). After localization 
and piloting, a short-axis stack was acquired parallel to the atrioventricular groove to 
cover the entire left ventricle in the standard way [12,13] for the 7/3mm (TE/TR 1.5/3.0 
ms, flip angle 60o, temporal resolution 45ms, slices/breathold 1, matrix size 256 x 202, 
7field of view 380 x 309 mm) identical to those parameters described by Hudsmith et 
al[12] and consistent with the parameters used by Moon et al [3], 7/0mm (TE/TR 1.5/3.0 
ms, flip angle 60o, temporal resolution 45ms, slices/breath-hold 1, matrix size 256 x 202, 
field of view 380 x 309 mm) as the above sequence but without the 3mm gaps, and 
6/4mm sequences (TE/TR 1.7/3.4 ms, flip angle 55o, temporal resolution 42ms, 
slices/breath-hold 2, matrix size 192 x 192, field of view 360 x 292 mm) duplicating that 
of the parameters described by Alfakih et al[1].  All images were acquired during breath-
hold in end-expiration. The total examination time was approximately 40 minutes for 
each subject.
Image Analysis 
Blinded analysis was performed using Argus software (Version 2002B, Siemens Medical 
Solutions, Erlangen, Germany). The end-systolic and end-diastolic frames were 
independently chosen by each observer.  Using the standard format [12,13] on each end-
diastolic frame, endocardial and epicardial borders were manually traced, and an 
endocardial border was manually traced on each end-systolic frame . The end-diastolic 
frame was defined as the image with the largest ventricular volume in each series, and the 
image with the smallest ventricular volume was chosen as the end-systolic frame.  The 
interventricular septum was included as a part of the left ventricle.  From these data, the 
ejection fraction, LV end-diastolic volume, LV end-systolic volume, stroke volume, and 
LV mass were calculated.  Myocardial mass was calculated by multiplication of the tissue 
volume by 1.05 g/cm3  (specific density of myocardium).
8Reproducibility and Variability
The inter-study reproducibility was assessed (MEH) by re-imaging seven subjects one to 
two days after the first scan.  Inter-observer variability was assessed by a second 
observer, analyzing seven of the data sets (JMF). For the intra-observer variability, one 
observer (MEH) analyzed the first seven data sets and waited six weeks to re-analyze the 
same seven data sets.  
Statistical Analysis 
All data are presented as mean +/- standard deviation (SD) unless stated otherwise. Inter-
study reproducibility, inter- and intra-observer variability were assessed using the method 
of Bland and Altman [14]. The coefficient of variability (CoV) was calculated as the SD 
of the differences between the two sets of measurements divided by the mean value of the 
parameter under consideration. Repeated measures of analysis of variance (ANOVA) 
were used to test for differences for continuous parameters among the three sequences 
used. Throughout the analyses, a two-sided p-value of <0.05 was considered statistically 
significant. All computations were performed with SPSS 11.5 (SPSS Inc., Chicago, US). 
Sample size calculations were performed before the initiation of the study based on the 
following assumptions: repeated measures ANOVA, SD for LV mass in healthy 
population [1], power 90%, alpha 0.05 and a difference of 10% of LV mass as the change 
to be detected. 
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9RESULTS 
CMR imaging was well tolerated by all subjects. All datasets were of good image quality 
and included in the study.  Images acquired of a healthy female subject using the three 
SSFP pulse sequence techniques are shown in Figure 1.    
The LV volumes, function and mass for each sequence are displayed in Table 1. There 
was no significant difference in all LV parameters using the three acquisition techniques 
(p>0.05), with similar normal ranges for healthy volunteers.  There was a trend for 
sequence 6/4mm to have an increased LV ejection fraction (p=0.07) and a reduced end-
systolic volume (p=0.05).  
There was no systematic difference in variabilities for the three sequences (Table 2).  The 
LV ejection fraction and LV mass for the intraobserver variability are displayed in Figure 
2.  The intraobserver variability was lowest using the 6/4mm technique for the LV 
ejection fraction, LV end-diastolic volume, and LV mass.  For the LV ejection fraction, 
the interobserver variability was lowest for the 7/3 mm technique, and highest for the 
6/4mm technique.  
10
DISCUSSION 
The purpose of this study was to quantify LV volumes, function and mass using three 
SSFP pulse sequence techniques to assess if the techniques are comparable and therefore 
interchangeable. We have shown that the three pulse sequences result in no significant 
differences in left ventricular volumes, function, and mass. Our results for the 6/4mm 
technique were comparable to the normal range of cardiac parameters published by 
Alfakih et al, using a Philips 1.5 T SSFP sequence using a 6 mm slice and 4 mm gap[1].  
The normal range published by Hudsmith et al using a Siemens 1.5 T SSFP sequence 
with a 7 mm slice and 3 mm gap showed cardiac parameters similar to our 7/3mm 
technique[12].  Kunz et al [8] examined left ventricular parameters using a contiguous 
8/0mm technique using a Siemens 1.5T SSFP sequence, showing results similar to our 
7/0mm contiguous technique.  
There was no significant difference in LV mass for all three sequences.  The 6/4mm 
technique showed a trend towards a decreased end-systolic volume.  This is possibly due 
to the larger interslice gap, leading to more geometric assumptions. The 6/4mm technique 
had a trend towards an increased ejection fraction.  The 6/4mm technique had a higher 
temporal resolution (i.e. lower TR) than the other two techniques, and therefore the 
captured end-systolic frame may be closer to the true end-systole, resulting in higher
ejection fractions when compared to the two other sequences with lower temporal 
resolution. The lower spatial resolution of the 6/4 mm technique (1.9 x 1.5 mm) 
compared to the other two techniques (1.5 x 1.5 mm) may also contribute to the observed 
trend for differences in LV end-systolic volume and ejection fraction.
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One would assume that although the 7/0mm technique has the longest acquisition time, it 
would be clinically superior to the other techniques because images are acquired 
contiguously, covering the entire ventricle, thus eliminating any gaps and not relying on 
geometric assumptions.  However, this study has shown that patient examination time can 
be minimized by using technique 7/3mm and 6/4mm, and result in similar and 
interchangeable cardiac parameter measurement.  The application of these two techniques 
are therefore valuable in a time-pressured clinical environment.   
The variability measurements of this study are comparable with those reported in the 
literature [1,3,11-13]. Overall, our results show low variability for all LV volumes, 
function, and mass results.  These variability data show that the tested techniques are 
reproducible and can be used in clinical practice. 
The LV ejection fraction is a frequently used cardiac functional  prognostic factor for 
patients, particularly in monitoring responses to therapeutic intervention [15] .  We have 
shown these three techniques provide the same information regardless of the 
manufacturer.  This is important for patients receiving care in different geographical 
locations or within a multi-centre trial.  We have provided evidence that may allow 
application and transfer of LV volume databases based on slightly different SSFP 
parameters, slice thickness and inter-slice gaps at different MRI sites, given a similar 
approach to post-processing. Future multi-centre studies may now be in a position to 
consider multi-vendor study designs for LV volume studies, aiding recruitment.
12
It is probable that variability in cardiac parameters result from variations in operators.  
Intra- and inter-operator variability studies of manual planning of CMR imaging resulted 
in insignificant statistical differences on LV parameters [16].  Because the variations due 
to different operators are insignificant, it was important to analyze if the errors were the 
result of the difference in the manufacturer, as completed in our study.  
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CONCLUSION 
We have shown the LV volume, function, and mass parameters acquired at 1.5T using 
three SSFP pulse sequence techniques in healthy controls are comparable and 
interchangeable.  This finding is particularly important for patients receiving care in 
different geographical locations and may allow multi-centre trials to include multiple 
vendor CMR centers, optimizing patient recruitment. However, future studies may need 
to confirm our findings in patients with dilated or hypertrophied hearts.
14
FIGURE LEGEND
Figure 1: Mid-ventricular short axis slices acquired during end-diastole in a healthy 
female subject using three steady-state free precession pulse sequence techniques, with 
endocardial and epicardial contours drawn on the left ventricle. A: 7 mm slice thickness 
with a 3 mm gap, one slice per breath-hold. B: contiguous images acquired with no gap at 
7mm, one slice per breath-hold. C: 6 mm slice thickness with a 4 mm gap, two slices per 
breath-hold. 
Figure 2: Intraobserver variability for LV mass and LV ejection fraction using the steady 
state free precession sequence without interslice gap for 7 healthy subjects (Bland-
Altman plot [14]). 
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Table 1: LV measurements in 21 healthy subjects
7/3mm 7/0mm 6/4mm P value
Ejection fraction (%)
67.2 ± 6.0 
(64.5-70.0)
67.4 ± 5.3
(65.0-69.8)
69.2 ± 5.7
(66.6-71.8)
0.07
Mass (g)
119.8 ± 32.4
(105.1-134.5)
122.2 ± 34.0
(106.6-137.7)
119.8 ± 33.6
(104.5-135.1)
0.35
End-diastolic volume (ml)
155.8 ± 34.0
(140.3-171.2)
159.7 ± 36.3
(143.2-176.2)
157.8 ± 34.7
(142.1-173.6)
0.10
End-systolic volume (ml)
50.6 ± 12.9
(44.8-56.5)
52.3 ± 16.0
(45.0-59.6)
48.2 ± 12.3
(42.6-53.8)
0.05
Stroke volume (ml)
105.1 ± 27.0
(92.8-117.4)
107.4 ± 24.4
(96.3-118.5)
109.7 ± 27.5
(97.2-122.2)
0.14
Values are expressed as Mean ± SD (95% confidence interval); ANOVA was used to test 
for differences for continuous parameters among the three sequences; p<0.05 is 
statistically significant.  
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Table 2: Variability of left ventricular measurements 
Intraobserver Interobserver Interstudy
Bias
(95% limits of 
agreement)
CoV
Bias
(95% limits of 
agreement)
CoV
Bias
(95% limits of 
agreement)
CoV
Ejection 
Fraction (%)
7/3mm
1.36 ± 3.43
(-5.36-8.08)
5.3
-2.75 ±  1.78
(-6.24-0.75)
2.8
2.06 ± 4.97
(-7.67-11.80)
7.8
Ejection 
Fraction (%)
7/0mm
3.14 ± 5.78
(-8.19-14.47)
9.1
-1.54 ±  2.91
(-7.24-4.15)
4.6
2.36 ± 5.40
(-8.22-12.95)
8.4
Ejection 
Fraction (%)
6/4mm
0.43 ± 2.49
(-4.45-5.31)
3.7
-1.19 ±  4.67
(-10.35-7.97)
7.2
2.47 ± 4.48
(-6.32-11.26)
6.8
Mass (g)
7/3mm
4.26 ± 6.67
(-8.80-17.33)
5.6
5.63 ±  10.28
(-14.51-25.77)
9.0
4.71 ± 12.21  
(-19.23-28.65)
10.3
Mass (g)
7/0mm
1.67 ± 6.94
(-11.93-15.27)
5.8
9.07 ±  7.53
(-5.69-23.82)
6.5
-0.74 ± 10.72
(-21.75-20.26)
8.9
Mass (g)
6/4mm
4.18 ± 4.95
(-5.51-13.88)
4.2
4.93 ± 9.54
(-13.77-23.63)
8.3
2.21 ± 14.85
(-26.90-31.32)
12.5
End-diastolic 
volume (ml)
7/3mm
-6.61 ± 9.14
(-24.52 – 11.30)
6.9
10.17 ±  6.57
(-2.70-23.04)
4.6
-0.73 ± 12.62
(-25.48 – 24.01)
8.5
End-diastolic 
volume (ml)
7/0mm
-6.45 ± 8.15
(-22.42 – 9.53)
5.3
13.17 ±  8.13
(-2.77-29.10)
5.6
-1.97 ± 14.22
(-29.83 – 25.89)
9.5
End-diastolic 
volume (ml)
6/4mm
-5.73 ± 7.56
(-20.54 - 9.09)
5.0
13.09 ±  15.05
(-16.41-42.59)
10.6
0.10 ± 18.98
(-37.10 – 37.29)
12.8
Values are expressed as Mean ± SD (95% confidence interval); CoV= coefficient of 
variability; Mean and confidence interval determined according to the Bland and Altman 
method [14].
